Abstract

How do we decide the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention?

Author(s): S-J Park & D-W Park

“To determine the optimal duration of dual antiplatelet therapy and the risk–benefit ratio for long-term dual antiplatelet therapy after drug-eluting stents, several clinical studies have been performed, but study findings are still equivocal.”